Clinical Trial

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Name: A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis — clinical trial record (NCT07276581)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LaunchPAD-RA

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

Protocol Amendment History 1 change

notable Trial sites expanded: 139 -> 144 locations 2026-05-06

Trial Details

NCT Number	NCT07276581
Lead Sponsor	AstraZeneca
Conditions	Rheumatoid Arthritis
Enrollment	320 participants
Start Date	2025-12-15
Primary Completion	2027-11-12 (estimated)
Study Completion	2028-08-18 (estimated)
Updated on ClinicalTrials.gov	2026-06-24